Theranostics for Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer with poor prognosis. Current endocrine therapy or anti HER-2 therapy is not available for these patients. Chemotherapeutic treatment response varies among patients due to the disease heterogeneity. To overcome these chall...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Hyeryeon, Kim, Kwangsoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857659/
https://www.ncbi.nlm.nih.gov/pubmed/36673082
http://dx.doi.org/10.3390/diagnostics13020272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857659/
https://www.ncbi.nlm.nih.gov/pubmed/36673082
http://dx.doi.org/10.3390/diagnostics13020272

Ejemplares similares